title: Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors.
abstract: Of 693,000 volunteer blood donors in Washington, D.C., who were screened for infection with human immunodeficiency virus type 1 (HIV-1) from July 1985 through December 1988, 284 tested positive on both enzyme immunoassay and Western blot assay. To determine the clinical importance of confirmed positive test results in asymptomatic blood donors, we followed 156 donors with positive Western blot assays and 80 donors with positive enzyme immunoassays but negative or indeterminate Western blots at 6-month intervals for a mean of 28 months. As compared with Western blot-negative persons, those with positive Western blots were significantly more likely to be black, male, and first-time donors and to have a history of venereal disease, generalized lymphadenopathy on examination, CD4-cell counts lower than 0.4 x 10(9) per liter, IgG levels higher than 18 g per liter, and antibody to hepatitis B core antigen on initial evaluation. In 17 (11 percent) of the Western blot-positive donors, the disease progressed to Class IV (symptomatic disease), according to the Centers for Disease Control system. CD4 counts below 0.2 x 10(9) per liter, IgA levels above 4 g per liter, abnormal proliferative responses to tetanus toxoid, and positive viral cultures were the strongest predictors of disease progression. Among the 80 donors with repeatedly reactive assay results but either negative or indeterminate Western blot assays, there was no evidence of HIV exposure in their histories, physical examinations, or laboratory evaluations, and manifestations of HIV infection developed in none of them. We conclude that a small number of persons with HIV infection continue to donate blood, despite attempts to exclude them, but that donors who test positive on enzyme immunoassay but persistently negative or indeterminate on Western blot assay probably do not represent a risk for the transmission of HIV.
authors.affiliation: Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md.
authors.forename: S F
authors.initials: SF
authors.lastname: Leitman
authors.forename: H G
authors.initials: HG
authors.lastname: Klein
authors.forename: J J
authors.initials: JJ
authors.lastname: Melpolder
authors.forename: E J
authors.initials: EJ
authors.lastname: Read
authors.forename: J I
authors.initials: JI
authors.lastname: Esteban
authors.forename: E M
authors.initials: EM
authors.lastname: Leonard
authors.forename: L
authors.initials: L
authors.lastname: Harvath
authors.forename: J W
authors.initials: JW
authors.lastname: Shih
authors.forename: R
authors.initials: R
authors.lastname: Nealon
authors.forename: J
authors.initials: J
authors.lastname: Foy
mesh_terms: D000386:AIDS-Related Complex; D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission; D001782:Blood Donors; D015153:Blotting, Western; D015496:CD4-Positive T-Lymphocytes; D004219:District of Columbia; D005006:Ethnicity; D006678:HIV / Q000302:isolation & purification; D006679:HIV Seropositivity / Q000175:diagnosis*; D006801:Humans; D007124:Immunoenzyme Techniques; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D011446:Prospective Studies; D012749:Sexually Transmitted Diseases / Q000150:complications
chemical_list: D007070:Immunoglobulin A; D007074:Immunoglobulin G